This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3
Vocabulary Work Group | Maturity Level: N/A | Ballot Status: Informative |
The manufacturer of a vaccine.
<CodeSystem xmlns="http://hl7.org/fhir"> <id value="v3-VaccineManufacturer"/> <meta> <lastUpdated value="2016-11-11T00:00:00.000+11:00"/> </meta> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p> Release Date: 2016-11-11</p> <table class="grid"> <tr> <td> <b> Level</b> </td> <td> <b> Code</b> </td> <td> <b> Display</b> </td> <td> <b> Definition</b> </td> </tr> <tr> <td> 1</td> <td> AB <a name="AB"> </a> </td> <td> Abbott Laboratories (includes Ross Products Division)</td> <td> Abbott Laboratories (includes Ross Products Division) <br/> </td> </tr> <tr> <td> 1</td> <td> AD <a name="AD"> </a> </td> <td> Adams Laboratories</td> <td> Adams Laboratories <br/> </td> </tr> <tr> <td> 1</td> <td> ALP <a name="ALP"> </a> </td> <td> Alpha Therapeutic Corporation</td> <td> Alpha Therapeutic Corporation <br/> </td> </tr> <tr> <td> 1</td> <td> AR <a name="AR"> </a> </td> <td> Armour [Inactive - use CEN]</td> <td> Armour [Inactive-use CEN] <br/> </td> </tr> <tr> <td> 1</td> <td> AVI <a name="AVI"> </a> </td> <td> Aviron</td> <td> Aviron <br/> </td> </tr> <tr> <td> 1</td> <td> BA <a name="BA"> </a> </td> <td> Baxter Healthcare Corporation</td> <td> Baxter Healthcare Corporation <br/> </td> </tr> <tr> <td> 1</td> <td> BAY <a name="BAY"> </a> </td> <td> Bayer Corporation (includes Miles, Inc. and Cutter Laboratories)</td> <td> Bayer Corporation (includes Miles, Inc. and Cutter Laboratories) <br/> </td> </tr> <tr> <td> 1</td> <td> BP <a name="BP"> </a> </td> <td> Berna Products [Inactive - use BPC]</td> <td> Berna Products [Inactive-use BPC] <br/> </td> </tr> <tr> <td> 1</td> <td> BPC <a name="BPC"> </a> </td> <td> Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne)</td> <td> Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne) <br/> </td> </tr> <tr> <td> 1</td> <td> CEN <a name="CEN"> </a> </td> <td> Centeon L.L.C. (includes Armour Pharmaceutical Company)</td> <td> Centeon L.L.C. (includes Armour Pharmaceutical Company) <br/> </td> </tr> <tr> <td> 1</td> <td> CHI <a name="CHI"> </a> </td> <td> Chiron Corporation</td> <td> Chiron Corporation <br/> </td> </tr> <tr> <td> 1</td> <td> CON <a name="CON"> </a> </td> <td> Connaught [Inactive - use PMC]</td> <td> Connaught [Inactive-use PMC] <br/> </td> </tr> <tr> <td> 1</td> <td> EVN <a name="EVN"> </a> </td> <td> Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.)</td> <td> Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.) <br/> </td> </tr> <tr> <td> 1</td> <td> GRE <a name="GRE"> </a> </td> <td> Greer Laboratories, Inc.</td> <td> Greer Laboratories, Inc. <br/> </td> </tr> <tr> <td> 1</td> <td> IAG <a name="IAG"> </a> </td> <td> Immuno International AG</td> <td> Immuno International AG <br/> </td> </tr> <tr> <td> 1</td> <td> IM <a name="IM"> </a> </td> <td> Merieux [Inactive - use PMC]</td> <td> Merieux [Inactive-use PMC] <br/> </td> </tr> <tr> <td> 1</td> <td> IUS <a name="IUS"> </a> </td> <td> Immuno-U.S., Inc.</td> <td> Immuno-U.S., Inc. <br/> </td> </tr> <tr> <td> 1</td> <td> JPN <a name="JPN"> </a> </td> <td> The Research Foundation for Microbial Diseases of Osaka University (BIKEN)</td> <td> The Research Foundation for Microbial Diseases of Osaka University (BIKEN) <br/> </td> </tr> <tr> <td> 1</td> <td> KGC <a name="KGC"> </a> </td> <td> Korea Green Cross Corporation</td> <td> Korea Green Cross Corporation <br/> </td> </tr> <tr> <td> 1</td> <td> LED <a name="LED"> </a> </td> <td> Lederle [Inactive - use WAL]</td> <td> Lederle [Inactive-use WAL] <br/> </td> </tr> <tr> <td> 1</td> <td> MA <a name="MA"> </a> </td> <td> Massachusetts Public Health Biologic Laboratories</td> <td> Massachusetts Public Health Biologic Laboratories <br/> </td> </tr> <tr> <td> 1</td> <td> MED <a name="MED"> </a> </td> <td> MedImmune, Inc.</td> <td> MedImmune, Inc. <br/> </td> </tr> <tr> <td> 1</td> <td> MIL <a name="MIL"> </a> </td> <td> Miles [Inactive - use BAY]</td> <td> Miles [Inactive-use BAY] <br/> </td> </tr> <tr> <td> 1</td> <td> MIP <a name="MIP"> </a> </td> <td> Bioport Corporation (formerly Michigan Biologic Products Institute)</td> <td> Bioport Corporation (formerly Michigan Biologic Products Institute) <br/> </td> </tr> <tr> <td> 1</td> <td> MSD <a name="MSD"> </a> </td> <td> Merck and Co., Inc.</td> <td> Merck & Co., Inc. <br/> </td> </tr> <tr> <td> 1</td> <td> NAB <a name="NAB"> </a> </td> <td> NABI (formerly North American Biologicals, Inc.)</td> <td> NABI (formerly North American Biologicals, Inc.) <br/> </td> </tr> <tr> <td> 1</td> <td> NAV <a name="NAV"> </a> </td> <td> North American Vaccine, Inc.</td> <td> North American Vaccine, Inc. <br/> </td> </tr> <tr> <td> 1</td> <td> NOV <a name="NOV"> </a> </td> <td> Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited)</td> <td> Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited) <br/> </td> </tr> <tr> <td> 1</td> <td> NYB <a name="NYB"> </a> </td> <td> New York Blood Center</td> <td> New York Blood Center <br/> </td> </tr> <tr> <td> 1</td> <td> ORT <a name="ORT"> </a> </td> <td> Ortho Diagnostic Systems, Inc.</td> <td> Ortho Diagnostic Systems, Inc. <br/> </td> </tr> <tr> <td> 1</td> <td> OTC <a name="OTC"> </a> </td> <td> Organon Teknika Corporation</td> <td> Organon Teknika Corporation <br/> </td> </tr> <tr> <td> 1</td> <td> PD <a name="PD"> </a> </td> <td> Parkedale Pharmaceuticals (formerly Parke-Davis)</td> <td> Parkedale Pharmaceuticals (formerly Parke-Davis) <br/> </td> </tr> <tr> <td> 1</td> <td> PMC <a name="PMC"> </a> </td> <td> Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux)</td> <td> Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) <br/> </td> </tr> <tr> <td> 1</td> <td> PRX <a name="PRX"> </a> </td> <td> Praxis Biologics [Inactive - use WAL]</td> <td> Praxis Biologics [Inactive-use WAL] <br/> </td> </tr> <tr> <td> 1</td> <td> SCL <a name="SCL"> </a> </td> <td> Sclavo, Inc.</td> <td> Sclavo, Inc. <br/> </td> </tr> <tr> <td> 1</td> <td> SI <a name="SI"> </a> </td> <td> Swiss Serum and Vaccine Inst. [Inactive - use BPC]</td> <td> Swiss Serum and Vaccine Inst. [Inactive-use BPC] <br/> </td> </tr> <tr> <td> 1</td> <td> SKB <a name="SKB"> </a> </td> <td> SmithKline Beecham</td> <td> SmithKline Beecham <br/> </td> </tr> <tr> <td> 1</td> <td> USA <a name="USA"> </a> </td> <td> United States Army Medical Research and Materiel Command</td> <td> United States Army Medical Research and Materiel Command <br/> </td> </tr> <tr> <td> 1</td> <td> WA <a name="WA"> </a> </td> <td> Wyeth-Ayerst [Inactive - use WAL]</td> <td> Wyeth-Ayerst [Inactive-use WAL] <br/> </td> </tr> <tr> <td> 1</td> <td> WAL <a name="WAL"> </a> </td> <td> Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics)</td> <td> Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics) <br/> </td> </tr> </table> </div> </text> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status"> <valueString value="External"/> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"> <valueInteger value="0"/> </extension> <url value="http://hl7.org/fhir/v3/VaccineManufacturer"/> <identifier> <system value="urn:ietf:rfc:3986"/> <value value="urn:oid:2.16.840.1.113883.5.144"/> </identifier> <version value="2016-11-11"/> <name value="v3 Code System VaccineManufacturer"/> <status value="active"/> <experimental value="false"/> <date value="2016-11-11T00:00:00+11:00"/> <publisher value="HL7, Inc"/> <contact> <telecom> <system value="url"/> <value value="http://hl7.org"/> </telecom> </contact> <description value=" The manufacturer of a vaccine."/> <caseSensitive value="true"/> <valueSet value="http://hl7.org/fhir/ValueSet/v3-VaccineManufacturer"/> <hierarchyMeaning value="is-a"/> <content value="complete"/> <concept> <code value="AB"/> <display value="Abbott Laboratories (includes Ross Products Division)"/> <definition value="Abbott Laboratories (includes Ross Products Division)"/> </concept> <concept> <code value="AD"/> <display value="Adams Laboratories"/> <definition value="Adams Laboratories"/> </concept> <concept> <code value="ALP"/> <display value="Alpha Therapeutic Corporation"/> <definition value="Alpha Therapeutic Corporation"/> </concept> <concept> <code value="AR"/> <display value="Armour [Inactive - use CEN]"/> <definition value="Armour [Inactive-use CEN]"/> </concept> <concept> <code value="AVI"/> <display value="Aviron"/> <definition value="Aviron"/> </concept> <concept> <code value="BA"/> <display value="Baxter Healthcare Corporation"/> <definition value="Baxter Healthcare Corporation"/> </concept> <concept> <code value="BAY"/> <display value="Bayer Corporation (includes Miles, Inc. and Cutter Laboratories)"/> <definition value="Bayer Corporation (includes Miles, Inc. and Cutter Laboratories)"/> </concept> <concept> <code value="BP"/> <display value="Berna Products [Inactive - use BPC]"/> <definition value="Berna Products [Inactive-use BPC]"/> </concept> <concept> <code value="BPC"/> <display value="Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne)"/> <definition value="Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne)"/> </concept> <concept> <code value="CEN"/> <display value="Centeon L.L.C. (includes Armour Pharmaceutical Company)"/> <definition value="Centeon L.L.C. (includes Armour Pharmaceutical Company)"/> </concept> <concept> <code value="CHI"/> <display value="Chiron Corporation"/> <definition value="Chiron Corporation"/> </concept> <concept> <code value="CON"/> <display value="Connaught [Inactive - use PMC]"/> <definition value="Connaught [Inactive-use PMC]"/> </concept> <concept> <code value="EVN"/> <display value="Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.)"/> <definition value="Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.)"/> </concept> <concept> <code value="GRE"/> <display value="Greer Laboratories, Inc."/> <definition value="Greer Laboratories, Inc."/> </concept> <concept> <code value="IAG"/> <display value="Immuno International AG"/> <definition value="Immuno International AG"/> </concept> <concept> <code value="IM"/> <display value="Merieux [Inactive - use PMC]"/> <definition value="Merieux [Inactive-use PMC]"/> </concept> <concept> <code value="IUS"/> <display value="Immuno-U.S., Inc."/> <definition value="Immuno-U.S., Inc."/> </concept> <concept> <code value="JPN"/> <display value="The Research Foundation for Microbial Diseases of Osaka University (BIKEN)"/> <definition value="The Research Foundation for Microbial Diseases of Osaka University (BIKEN)"/> </concept> <concept> <code value="KGC"/> <display value="Korea Green Cross Corporation"/> <definition value="Korea Green Cross Corporation"/> </concept> <concept> <code value="LED"/> <display value="Lederle [Inactive - use WAL]"/> <definition value="Lederle [Inactive-use WAL]"/> </concept> <concept> <code value="MA"/> <display value="Massachusetts Public Health Biologic Laboratories"/> <definition value="Massachusetts Public Health Biologic Laboratories"/> </concept> <concept> <code value="MED"/> <display value="MedImmune, Inc."/> <definition value="MedImmune, Inc."/> </concept> <concept> <code value="MIL"/> <display value="Miles [Inactive - use BAY]"/> <definition value="Miles [Inactive-use BAY]"/> </concept> <concept> <code value="MIP"/> <display value="Bioport Corporation (formerly Michigan Biologic Products Institute)"/> <definition value="Bioport Corporation (formerly Michigan Biologic Products Institute)"/> </concept> <concept> <code value="MSD"/> <display value="Merck and Co., Inc."/> <definition value="Merck & Co., Inc."/> </concept> <concept> <code value="NAB"/> <display value="NABI (formerly North American Biologicals, Inc.)"/> <definition value="NABI (formerly North American Biologicals, Inc.)"/> </concept> <concept> <code value="NAV"/> <display value="North American Vaccine, Inc."/> <definition value="North American Vaccine, Inc."/> </concept> <concept> <code value="NOV"/> <display value="Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited)"/> <definition value="Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited)"/> </concept> <concept> <code value="NYB"/> <display value="New York Blood Center"/> <definition value="New York Blood Center"/> </concept> <concept> <code value="ORT"/> <display value="Ortho Diagnostic Systems, Inc."/> <definition value="Ortho Diagnostic Systems, Inc."/> </concept> <concept> <code value="OTC"/> <display value="Organon Teknika Corporation"/> <definition value="Organon Teknika Corporation"/> </concept> <concept> <code value="PD"/> <display value="Parkedale Pharmaceuticals (formerly Parke-Davis)"/> <definition value="Parkedale Pharmaceuticals (formerly Parke-Davis)"/> </concept> <concept> <code value="PMC"/> <display value="Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux)"/> <definition value="Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux)"/> </concept> <concept> <code value="PRX"/> <display value="Praxis Biologics [Inactive - use WAL]"/> <definition value="Praxis Biologics [Inactive-use WAL]"/> </concept> <concept> <code value="SCL"/> <display value="Sclavo, Inc."/> <definition value="Sclavo, Inc."/> </concept> <concept> <code value="SI"/> <display value="Swiss Serum and Vaccine Inst. [Inactive - use BPC]"/> <definition value="Swiss Serum and Vaccine Inst. [Inactive-use BPC]"/> </concept> <concept> <code value="SKB"/> <display value="SmithKline Beecham"/> <definition value="SmithKline Beecham"/> </concept> <concept> <code value="USA"/> <display value="United States Army Medical Research and Materiel Command"/> <definition value="United States Army Medical Research and Materiel Command"/> </concept> <concept> <code value="WA"/> <display value="Wyeth-Ayerst [Inactive - use WAL]"/> <definition value="Wyeth-Ayerst [Inactive-use WAL]"/> </concept> <concept> <code value="WAL"/> <display value="Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics)"/> <definition value="Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics)"/> </concept> </CodeSystem>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.